SIRT6 and metabolic dysfunction-associated steatohepatitis: SIRT6 is reduced by proteasome-mediated degradation via ubiquitination in the hepatocyte cytoplasm when NAFL progresses to NASH in NAFLD patients compared to healthy individuals (65, 75).